Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Guided Therapeutics's total debt was $11.00K at Jun 30, 2026. For fiscal 2025 it was $23.00K, down 51.1% from the year before. Over ten years it grew -16.1% a year on average. The highest annual figure on record is $1.39M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.00K | -51.1% |
| FY2024 | Dec 31, 2024 | $47.00K | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $17.00K | -84.5% |
| FY2021 | Dec 31, 2021 | $110.00K | +115.7% |
| FY2020 | Dec 31, 2020 | $51.00K | -92.1% |
| FY2019 | Dec 31, 2019 | $646.00K | -36.3% |
| FY2018 | Dec 31, 2018 | $1.01M | -26.9% |
| FY2017 | Dec 31, 2017 | $1.39M | +37.6% |
| FY2016 | Dec 31, 2016 | $1.01M | +657.9% |
| FY2015 | Dec 31, 2015 | $133.00K | -18.4% |
| FY2014 | Dec 31, 2014 | $163.00K | -23.1% |
| FY2013 | Dec 31, 2013 | $212.00K | +5200.0% |
| FY2012 | Dec 31, 2012 | $4.00K | -84.0% |
| FY2011 | Dec 31, 2011 | $25.00K | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.00K | -68.6% |
| Q1 FY2026 | Mar 31, 2026 | $17.00K | -58.5% |
| Q4 FY2025 | Dec 31, 2025 | $23.00K | -51.1% |
| Q3 FY2025 | Sep 30, 2025 | $29.00K | -45.3% |
| Q2 FY2025 | Jun 30, 2025 | $35.00K | -40.7% |
| Q1 FY2025 | Mar 31, 2025 | $41.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $47.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $53.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $59.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $17.00K | -84.5% |
| Q3 FY2022 | Sep 30, 2022 | $32.00K | +77.8% |
| Q2 FY2022 | Jun 30, 2022 | $47.00K | +95.8% |
| Q1 FY2022 | Mar 31, 2022 | $67.00K | +31.4% |
| Q4 FY2021 | Dec 31, 2021 | $110.00K | +115.7% |
| Q3 FY2021 | Sep 30, 2021 | $18.00K | -64.0% |
| Q2 FY2021 | Jun 30, 2021 | $24.00K | -52.0% |
| Q1 FY2021 | Mar 31, 2021 | $51.00K | -92.1% |
| Q4 FY2020 | Dec 31, 2020 | $51.00K | -83.4% |
| Q3 FY2020 | Sep 30, 2020 | $50.00K | -95.1% |
| Q2 FY2020 | Jun 30, 2020 | $50.00K | -96.4% |
| Q4 FY2019 | Dec 31, 2019 | $646.00K | -35.9% |
| Q1 FY2019 | Mar 31, 2019 | $308.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $1.01M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.39M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.01M | – |
See a number that looks wrong?